The EMA points out that there is not “sufficient clinical evidence” for a fourth dose in people over 70 years of age

The European Medicines Agency (EMA) has indicated that at the moment there is “sufficient clinical evidence” to support the administration of a second booster dose of the vaccine against covid-19 in those over 70 or 80 years of age, as is happening in some European countries.

“For the EMA to issue a recommendation in this regard, sufficient clinical evidence would have to be seen first”explained at a press conference this Thursday the head of the EMA’s Strategy for Biological Health Threats and Vaccines, Marco Cavalieri.

In any case, he pointed out that the EMA “will continue to examine all available data on the use of a second booster dose of mRNA vaccines.” “At this time, there is not enough evidence in this regard,” he insisted.

Regarding the booster dose with the Pfizer vaccine in adolescents from 12 years of age, Cavaleri has reported that Israel has provided safety data on almost 400,000 adolescents who had received this third dosewithout “new security problems” being identified.

Likewise, it has highlighted that the data show that a booster dose of the Moderna vaccine “can be administered as soon as 3 months after the primary vaccination if necessary”. “The EMA has made it possible to reduce the interval between primary vaccination and the booster dose with this vaccine to three months,” has remembered.

On the other hand, it has been announced that “In the coming weeks, progress could be made towards submitting a marketing authorization application” for the monoclonal antibody cocktail ‘Evusheld’which is expected to be effective against the BA.2 omicron subvariant.

In relation to the deployment of ‘Nuvaxovid’, the Novavax vaccine, which is arriving these days in the Member States, the leader of the European regulatory body has highlighted that “Preliminary data is showing that the immune response after primary vaccination achieves omicron neutralization although this is lower than for other variants of covid-19, similar to what we have seen with mRNA vaccines “.

Finally, Cavaleri has warned that although the omicron wave “seems to lose some strength” in Europe, one must remain “cautious as this variant is highly transmissible and new sub-variants may yet emerge”.

“It is clear that people who do not get vaccinated suffer the harshest consequences of covid-19. We encourage all EU citizens to get vaccinated or, if eligible, get a booster shot without further delay“, has riveted.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button